Discoveries about cannabidiol and its effectiveness against tobacco addiction
Recent research has shown that cannabidiol (CBD) can be a valuable tool in the fight against smoking. Two studies conducted at University College London have yielded promising results, leading to the development of products aimed at this purpose. These discoveries have generated interest in the market and have led to initiatives to offer less harmful alternatives to traditional cigarettes.
Studies on the effectiveness of CBD in reducing tobacco consumption
In the first study, published in 2013, twelve smokers were given a CBD inhaler, while another group was given an inhaler with a placebo. The results showed that those who used the CBD inhaler reduced their cigarette consumption by 40%, compared to the group that used the placebo. This finding suggests that compounds that affect the endocannabinoid system may be beneficial in the fight against nicotine.
In the second study, carried out in 2018 with the participation of 30 smokers, a dose of 800 mg of CBD or a compatible placebo was administered. The results indicated that the CBD dose helped reduce the attraction to tobacco, especially during nocturnal withdrawal. These findings supported the effectiveness of CBD demonstrated in the previous study.
Addressing addiction and habit
Quitting smoking not only means overcoming the physical addiction, but also combating an ingrained habit. For many, smoking is associated with specific social and emotional situations, making it difficult to quit. However, using CBD hemp flower cigarettes can help mitigate withdrawal effects, allowing individuals to transition away from nicotine without completely giving up the habit. Although it is considered a less harmful option, it should be noted that smoke itself always carries health risks.
Alternative products with CBD and their availability on the market
In Switzerland, CBD products have been introduced to the market as an alternative to tobacco cigarettes. Large supermarket chains, such as Lidl, have begun to sell hemp flower cigarettes with a very low proportion of THC, presenting them as a relaxing option with less harmful effects on health.
These cigarettes are made with ‘light’ marijuana, with less than 1% THC, making them legally marketable in Switzerland. Consumers have expressed that, despite the low THC concentration, the taste and sensations are similar to traditional tobacco. This availability on the market has generated interest and discussions about regulation and possible benefits for smokers.
Pilot projects and market evolution in Switzerland
Several Swiss cities, including Geneva, Zurich and Basel, are carrying out pilot projects related to the controlled consumption and commercialization of cannabis. These projects aim to evaluate the effects of regulated consumption in clubs and analyze the possibility of sales in pharmacies. The purpose is to understand how market regulation can combat illegal trade and allow better control of product quality, as well as tax collection and preventive measures.
These advances in Switzerland raise questions about the possibility of other countries following suit, offering cannabis alternatives to combat tobacco addiction. As the market evolves, it is important to understand the potential benefits and risks associated with using CBD products as a smoking cessation aid.
